chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Breakthrough case admission after 2 vaccines  Moderna 7/28/21 lot# 059E21A;  Moderna 8/25/21 lot# 062E21A
"covid arm" ie. large red rash at injection site, appearing 9 days after receiving first dose of the vaccine  https://www.health.com/condition/infectious-diseases/coronavirus/covid-arm-rash-moderna
A spontaneous report has been received from a Health Professional concerning a 13 year old, female subject, who had been receiving nasal FLUMIST Quadrivalent. FLUMIST Quadrivalent was started on an unknown date. It was reported that patient was inadvertently administered expired FLUMIST Quadrivalent on 04-JAN-2015. The outcome of the event of inadvertently administered expired FLUMIST Quadrivalent was unknown. The report was considered to be non-serious by company physician.
The next morning my nose and throat were very sore. Nose became sensitive to the touch. By end of day one I had developed a rash similar to shingles inside of my nose and on the roof of my mouth. I was not able to breath from my nose due to the rash which became scab like.
Hives developed on his face approximately 20 min following administration of vaccines. He was given 3ml of Benadryl, and hives resolved within 20 min.
A patient received an expired MMR II; This spontaneous report was received from a nurse prescriber and refers to a patient of unknown age and gender.   The patient pertinent medical history, concurrent conditions and concomitant therapies were not reported.  On 22-JUN-2021, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) (lot # S015962, expiration date: 23-MAY-2021) 1 dose for prophylaxis.
On 5/30/02, received vaccinations. On 6/19/02, rash appeared on lower right leg but normal behavior and healthy. On 6/23/02, went to large public water park and rash was present but normal behavior with rash. On 7/4/02, attended festivities, rash present but normal behavior and healthy. On 7/5/02, had 99.3F (under arm) fever after waking from PM nap (approx. 14:00) and rash had spread to back. On 7/6/02, woke with 101F fever and was given Motrin. Took 4 hour nap (very unusual) and temperature was 102F upon waking and ate a little. Temperature was down to 100.6F at bed time. On 7/7/02, temperature 101.3F at wake up and gave Motrin. Had decreased activity all day. No bowel movement all day. Rash was on both legs, back and chest/abdomen. Rash is milder on torso that legs. Temperature 101.4F after PM nap. On 7/8/02, temperature 101.6F at wake up and gave Motrin. Decreased activity and food/fluid intake all day. No fever after this point and activity and appetite returned to normal by PM/next day. When rash first appeared, I applied hydrocortisone cream regularly but it had no effect. MD said the rash did not look like the rash that comes from the chickenpox shot. He recommended moisturizers and waiting for new skin to "push rash out". After MD visit, I used olive oil liberally, several times a day. The rash eventually cleared up by the end of 7/02. My son has had no history of rashes before of since this incident. I believe the rash was caused by the shot he received for chickenpox.
After 1st dose, and within 1st week, noticed twitching around both eyes, then twitching throughout body, developed neuropathy in right leg, foot and hand.
Diarrhea; This case was reported by a consumer via call center representative and described the occurrence of diarrhea in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced diarrhea. On an unknown date, the outcome of the diarrhea was unknown.   It was unknown if the reporter considered the diarrhea to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter was mother-in-law of patient.  The patient experienced diarrhea after receiving what they believe was the Shingrix vaccine. The reporter did not consent to followup. This case linked with US2021005930 and US2021005937, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021005930:Same reporter US-GLAXOSMITHKLINE-US2021005937:Same reporter
Shot was administered in the right arm, redness  and increased sensitivity of right arm and both thighs (from hip to knee).   Appeared as sunburn on legs.
Pt was vaccinated at approximately 11:40 AM today. She was given the Pfizer vaccine and observed for 15 minutes. During the observation period, the patient complained of tingling in her throat. She had no throat or tongue swelling, no difficulty breathing, SOB. She was offered PO Benadryl but the patient declined and said she would like to "wait it out". She drank water, ate a snack and felt better. Pt left but upon walking outside to her car she said she felt like she couldn't breath so she returned to the vaccine clinic. Pt reported feeling better upon coming back inside. She had no further c/o SOB or trouble breathing. Pulse ox 99-100% on RA and HR WNL. Pt was given PO Benadryl at 1230 PM. Pt is feeling better. Brother picked her up. Instructed to go to the ER if symptoms return and to inform her doctor of what happened.
Extreme nerve -like pain up and down left arm, elbow, wrist, hand, fingers, shoulder, upper left back.  Pain started a few minutes after injection. Pain continues. It has been 4 days.
Redness and swelling at site of injection started 9/28/16. Seen in office on 9/29/16 and at that time left arm with erythema above deltoid down to elbow, warm, taut on lateral surface, soft on medial surface. Patient given Cephalexin 250/5 for treatment of cellulitis.
Information has been received from a registered nurse concerning a female who was vaccinated with PNEUMOVAX 23 on an unspecified date.  Subsequently, the patient experienced blotches and difficulty breathing.  The patient had to go to the emergency room.  The patient recovered on an unspecified date.  Additional information is not expected.
Myalgia, NauseaVomiting, SORE ARM, SWEATING Narrative:  Other Relevant History:
Red bumps, Blistery, itchy generalized rash; Red bumps, Blistery, itchy generalized rash; crazy itching all over; At the site of the injection now has all red bumps all around it; It started red bumps then the blister end loose yellow; At the site of the injection now has all red bumps all around it; It started red bumps then the blister end loose yellow; This is a spontaneous report from a contactable consumer (patient). A 64-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EP7533) via an unspecified route of administration, administered in the left arm on 11Apr2021 at 10:30 (at the age of 64-year-old) as dose 2, single for COVID-19 immunization at hospital. Medical history included hypothyroidism and Allergies to medications, food, or other products included PCN, ASA, NSAIDS. Concomitant medications included levothyroxine sodium (SYNTHROID); cyanocobalamin, folic acid (VITAMIN B12 & FOLIC ACID), Vitamin D; all taken for an unspecified indications, start and stop dates were not reported. Historical vaccine included first dose of BNT162B2 (Lot Number: ER8727) via an unspecified route of administration, administered in the left arm on 21Mar2021 at 15:15 (at the age of 64-year-old) as dose 1, single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19 and not received any other vaccines within 4 weeks. Since the vaccination, the patient was not tested for COVID-19. It was reported that, Patient received vaccine on 11Apr2021 (Sunday). The following Wednesday on an unspecified date in Apr2021, patient started developing to a look like a blistery rash on his arm, the opposite arm of the injection site. The patient experienced red bumps, blistery, itchy generalized rash. And at the site of the injection now had all red bumps all around it, It started with red bumps then the blister end loose yellow. He was suffering with crazy itching all over. And it was thought to be poison Ivy. Since then or since Wednesday, It was not generalized at that time, It was growing. So the only thing that it could be is the vaccine. So, now it was generalized at the time of report. Patient received treatment for the events with Calamine lotion. Outcome of the events was not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Patient left clinic after receiving vaccine and stated he began to feel intense muscle aches from his neck down to his thighs once he was in his vehicle. Pt called for assistance because the pain was severe and he could not easily move. He was placed in a WC and taken into the clinic where he was further assessed; his vitals were WNL except for elevated BP which is not unusual given his HTN diagnosis.
Information has been received from a physician concerning an 11 year old female patient who on an unspecified date was vaccinated IM with her first dose of HPV rL1 6 11 16 18 VLP vaccine (yeast). Within one to two days after administration, the patient developed headache and fever. No medical attention was sought. Her outcome was not reported. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 10/13/2006.  Information has been received from a physician concerning a 11 year old female patient who on an unspecified date was vaccinated IM with her first dose of GARDASIL.  Within one to two days after administration, the patient developed headache and fever.  No medical attention was sought.  Her outcome was not reported.  Follow up information has been received regarding the 11 year old white female with no medical history who at 2:30 p.m. on 19-SEP-2006 was vaccinated in the right arm with her first dose of GARDASIL, lot #653735/0688F.  She received her first dose of ADACEL in the left arm at the same time.  At 7:00 p.m. on the same day, she developed a headache.  She woke up during the night with severe headache.  Fever was approximately 101-102.  On the afternoon of 20-SEP-2006 she was better and able to attend school.  It was reported that she recovered from headache and fever on the afternoon of 20-SEP-2006.  Additional information is not expected. This is a consolidation of two reportes concerning the same patient. WAES #0160USA00860 was previously submitted on 13-OCT-2006.
approx 2 wks p/vax, pt was adm to hosp w/lobar pneumonia; citrobacter frunedii was isolated from the sputum;
Left arm pain started day of vaccine; symptoms diarrhea, vomiting, cough. Left arm was red, swollen, indurated. Patient treated with IV--normal saine, Phenergan, and Rocephin.
Took 2nd Moderna shot on Wednesday April 28. Rash began next day after shot. Shoulder muscle was sore, lasted two days after shot. Rash was around the area of shot, all pink, about 3 inches long vertically and 2 inches wide. Itchy and hurt when touch. Today is Monday, 5 days after shot, rash is slowing going away and improving. No other rash in other parts of my body. Other symptoms: some fatigue and headache and muscle soreness which lasted for two days after shot. Took tylenol and symptoms went away.  I did not get rash on 1st Moderna shot on March 31 but did get sore shoulder muscle for 4 or 5 days. No symptoms.
ACT HIB VACCINE MIXED INCORRECTLY WITH STERILE DILUENT FROM MERCK. VERIFIED WITH MEDICAL DIRECTOR AT SANOFI THAT THIS DOSE WAS NOT INVALID AND THAT STERILE DILUENT CAN BE USED IN PLACE OF ACT HIB DILUENT.
pt developed uri sx and low grade fever 2 days after Flumist which was not unexpected (11/24/10) - then on 12/1/10 developed swelling and pain and rash on feet - went to ER and was diagnosed with Henoch Schonlein purpura - she is all better as of 12/6/10
therapy non-responder  This case was reported by a nurse and described a subject (age and gender unknown) who did not respond to immunization to hepatitis B vaccine recombinant (Engerix-B).  On unspecified dates, the subject received Energix-B. On an unspecified date before 12 May 2006, a hepatitis B surface antibody titer was negative. It was reported that the titers were taken from one to five months after the third dose of Engerix-B was received. No adverse events were reported.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 05-FEB-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 27 degrees Fahrenheit (-2.77 degrees Celsius) (lowest recorded temperature) for 876 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
L upper arm, L shoulder and L side of neck pain. Treated with massage, stretching and Ibuprofen. Symptoms are getting better but on-going.
performed 30 min observation, left to go back to work, said he felt like his heart was racing and looked at his smart watch and HR was 168. Upon arriving back at clinic, denies dyspnea or resp concerns. Reports feeling hot, anxious, heart racing, pt was sweating. HR 152 BP 150/100, Pulse ox 99%. Patient taken to ED to be evaluated.
Lasting 4 days- Nausea, vomiting, aches, fatigue, fever, chills  Lasting 2.5 weeks -Leg edema
Sever itch around the body progressed to redness.  Epinephrine was administer and two tablets of Medrol.
got sick; Initial information was received on 22-Nov-2020 regarding an unsolicited valid non-serious social media case from a consumer via Social media.  This case involves patient (unknown demography) who got sick (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got sick (illness) (24 hours) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
One of twenty-one cases:  A non-serious, spontaneous event of a half dose of FLUMIST administered was received from a registered nurse.  The event occurred in a seventh grade, adolescent female.  No medical or drug history was reported for this adolescent.  FLUMIST was inadvertently administered in one nostril to 21 children during a flu clinic at an elementary school.  The nurse administering the doses had been trained on administering FLUMIST but forgot to take off the divider clip; 21 children received only half a dose.  No adverse effects were reported; the event is considered resolved.
After I got my booster, I had lots of allergy that I was never allergic to; It's like, I am allergic to everything, I never had allergy before; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), in Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunization; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunization. The following information was reported: HYPERSENSITIVITY (non-serious), outcome "unknown", described as "After I got my booster, I had lots of allergy that I was never allergic to; It's like, I am allergic to everything, I never had allergy before".  Additional information: Consumer stated had the two and my sister, my brother in law and myself, we all have the two Pfizer, you know that Covid vaccine and brother in law had two booster and my sister and myself had one booster (further clarification unknown). I just wanted to know, does anybody else report it. After the patient got booster had lots of allergy that was never allergic to. It's like, the patient was allergic to everything, never had allergy before.Consumer added after got first booster in last November, that's you know, my allergy started. Not the first two, the first booster.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
A report has been received from a Health Professional concerning a 44 year old, Female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT started on an unknown date. The patient experienced administered expired FLUMIST QUADRIVALENT which started on 14-Jan-2014. The outcome of the event of administered expired FLUMIST QUADRIVALENT is unknown. The report was considered to be non-serious by the reporter.
Seriousness criteria other medically significant (OMIC). Initial report received on 10/12/06 from the vaccine safety information sharing system on behalf of a health care professional. A teenager had received an Influenza vaccine on an unspecified date, and within a few weeks developed acute disseminated encephalomyelitis. The pt did not require any treatment. The vaccine trade name, manufacturer, route and site of administration was not reported. Per the reporter, the health care professional was questioning whether meningococcal vaccine (or any other vaccine) can cause a recurrence of acute disseminated encephalomyelitis (ADEM) (assuming a causal relationship, for the event, which, in his opinion, has not been firmly established). No other information was provided. The recovery status of the pt is unk.
Developed constant harsh cough. Cough was dry at times but often productive of clear mucous. SOB. Congestion. I still have these but they are very slowly waning over time. This is 15 days post vaccine.  Exhausted from coughing & lack of sleep from coughing. Also had high fever, aches & chills. Temp was over 104 F starting suddenly on Saturday Jan 23 that waned & was normal by Wednesday Jan 26th.
February 14th 12pm fever chills, body aches. Pain and swelling in left armpit area.  Pain and swelling in left side of neck just above collar bone. Saw pmd on February 16th and BP was 140/100. Heart 100. Was prescribed attenolol and follow up in 2 weeks.  Advised to check BP and pulse ox twice daily
Admitted for COVID pneumonia. Treated with steroids, remdesivir, plasma, zinc, singulair, eliquis. Gradually her symptoms improved but then she developed orthostatic hypotension while in the hospital Improved and discharged to SNF.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. On an unknown date, the patient may have received an improperly stored dose of one of the following vaccines: PEDVAXHIB lot # M047666, expiration date 24-OCT-2019, GARDASIL 9 lot # M041990, expiration date 28-JUN-2019 or ROTATEQ lot #M018957 with expiration date 22-NOV-2017 or lot #M040269 with expiration date 28-APR-2018. The nurse was not sure which of the vaccines the unspecified patient received. No adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 32 degrees Fahrenheit for 2 hours. Data logger was involved. There were no previous excursions reported.
CHIEF COMPLAINT:   AMS  HISTORY OF PRESENT ILLNESS:     History is very limited in this patient because she is very confused and altered.   71-year-old female brought in by ambulance for evaluation of altered mental status.  2 weeks ago the patient was out to dinner and her baseline mental status was completely normal at that time.  Last known well was 4 days ago on Friday night.  According to the niece, the patient was dropped off at home and placed in her rocking chair.  At that time the patient was more confused than usual slurring her speech slightly but was very insistent that she was "okay ".  Next day the niece called the house and the patient sounded better.  There was an ice storm the following day and the weather made driving almost unmanageable, and for this reason the patient was left at home for the next couple days.  When the patient stopped answering her phone calls the niece became concerned and went to visit her today.  The niece found the patient today in the same rocking chair and wearing the same exact close.  The suspicion is that the patient not moved at all from the chair for the past 4 days.  EMS tells me that the patient was covered in urine and soaking wet.   The patient herself makes eye contact, is able to speak in 1-2 word sentences, but is clearly confused.  He can answer simple questions yes or no, and often says "I am fine ".
headache within 4 hours (not severe) arm pain (site of injection within 4 hours) lasted through 12/30 next morning - chills, muscle pains (sharp/fast) entire day 12/30 fatigue entire day 12/30 skin hurt (especially in shower, felt like water was burning my skin) entire day 12/30
Breakthrough case admission after 2 vaccines Pfizer 1/22/21 Lot# EL9261;  Pfizer 2/12/21 Lot# EL9267
14OCT strange feeling in throat started & cont;18OCT lips became edematous & wheezing started;has the sensation of a large lump in throat w/gen pruritus;21OCT hands & feet became swollen, painful & fire red;23OCT gen rash devel w/pruritus
My father had immediate swelling to the left foot with intense pain systemically targeting joints. He was unable to walk and needed the aid of a rollator to remain mobile, which he was not using preceding the vaccinations. It progressed requiring immediate attention from a medical doctor. He was scheduled to see Dr. on April 27, 2021 for the swelling and pain of the left foot and knee. While seated in the doctor's office, pt. suffered an expressive aphasia stroke on the left side of his brain. He was transported to ER to receive emergency medical care. A CT of the brain confirmed a CVA and TPA (clot buster) was administered by Dr., attending neurologists and stroke specialists. Since April 2021, pt. has needed both physical and occupational therapy to deal with systemic inflammation, weakness, and pain. He is no longer able to drive and continues to require the aid of a walker or cane.
around 340 pt recvd MMR walked up to front counter blacked out, fell down on floor father & mother first to aide pt by putting head in lap; pt speaking rationally pulse 72- BP 118/80- skin warm- breathing OK no open wounds- ambulance called
Received injection on 3-3-2021. On 3-7-2021 I noticed a large red blotch at the injection site that was not there previously.  It's size is 3 1/2" by 1 1/2". No pain at site. Slight itching. Skin is not raised nor are there any blisters. No other side effects associated with vaccine.
Red, warm, swollen and painful rash just below vaccine site, starting 8 days after the shot and lasting for 2-3 days ("covid arm")
On July 20, 2021 I found my mother deceased in her home. She was not sick and died suddenly and unexpectedly of a cardiopulmonary embolism.
developed bullous pemphigoid but moved out of state and kept hoping it'd get better... finally broke down on Oct 1, 2021 to go to the doctor to get medical treatment.  Urgent Care    They would not test for bullous pemphigoid but confirmed that it "looked like it" - said to try their prescriptions first and then request a referral to a dermatologist if I needed further help / testing.... said all skin conditions are similar and prescribed me topical creams and an antibiotic.
Dose squirted out of syringe and got in face. Immediately wiped face with paper towel. As of now, no other effects reported. Given second dose in right arm.